Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Angel Pond Holdings CorpPOND · Entity 121474 | Director | May 06, 2021 | May 11, 2021 |
| Bellerophon Therapeutics, Inc.BLPH · Entity 108982 | Director | June 07, 2023 | June 09, 2023 |
| ChronoScale Holdings CorpEKSO · Entity 4331 | Director | May 16, 2025 | May 19, 2025 |
| DEL MONTE CORPFDP · Entity 4683 | Director | May 04, 2026 | May 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Angel Pond Holdings Corp
Report date May 06, 2021 · Filed May 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Ordinary SharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-05-06 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333-253990), as amended, under the heading "Description of Securities--Founder Shares," the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of, or immediately following, the issuer's initial business combination, on a one-for-one basis, subject to certain adjustments, and have no expiration date.
Bellerophon Therapeutics, Inc.
Report date June 07, 2023 · Filed June 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.83 · Expires 2033-06-07 | Direct | 14,607 |
Reported balance
After 2023-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-07 · Grant · Disposed 14,607 · Balance 14,607 F1: This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023. F2: This option vests in full on June 7, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023.
F2: This option vests in full on June 7, 2024.
ChronoScale Holdings Corp
Report date May 16, 2025 · Filed May 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 456,707 |
Reported balance
After 2025-05-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-05-16 · Grant · Acquired 236,202 · Balance 456,707 F1: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2: This award of RSUs was granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date. F3: Includes 236,202 unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2: This award of RSUs was granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
F3: Includes 236,202 unvested RSUs.
DEL MONTE CORP
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 31,878 |
Ending reported balance
After 2026-05-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-05 · Exercise / conversion · Acquired 4,489 · Balance 31,729 Row 2 · 2026-05-05 · Exercise / conversion · Acquired 149 · Balance 31,878 F1: 0.2267 Dividend Equivalent Units ("DEUs") were deducted from the total due to fractional shares being paid in cash. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-05 · Exercise / conversion · Disposed 149.2267 · Balance 0 F2: Each DEU represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3: Includes 149.2267 shares acquired through a dividend reinvestment plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-05 · Exercise / conversion · Disposed 4,489 · Balance 0 F4: The RSUs convert to Ordinary Shares on a one-for-one basis. F5: These RSUs vested on the one-year anniversary of the grant date (May 5, 2025). |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,717 |
Reported balance
After 2026-05-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-04 · Grant · Acquired 3,717 · Balance 3,717 F4: The RSUs convert to Ordinary Shares on a one-for-one basis. F6: These RSUs shall vest on the one-year anniversary of the grant date (May 4, 2026). |
Filing footnotes · ownership attribution and instrument terms
F1: 0.2267 Dividend Equivalent Units ("DEUs") were deducted from the total due to fractional shares being paid in cash.
F2: Each DEU represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate.
F3: Includes 149.2267 shares acquired through a dividend reinvestment plan.
F4: The RSUs convert to Ordinary Shares on a one-for-one basis.
F5: These RSUs vested on the one-year anniversary of the grant date (May 5, 2025).
F6: These RSUs shall vest on the one-year anniversary of the grant date (May 4, 2026).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2021 Filed Jan 4, 2022 21:10 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | GrantStock Options (right to buy) · Derivative | 21,828 | $3.10 Strike: $3.10 | $67,666.80 |
DisclosureSEC source: 0001415889-22-000188 · form4-01042022_040117.xml · derivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 Underlying: Common Stock · 21,828 shares Expires 2031-12-31 Read SEC document |
| December 10, 2021 Filed Dec 15, 2021 00:58 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 12.5447 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000355 · wf-form4_163952990835672.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29.5077 Underlying: Ordinary Shares · 12.5447 shares Expires not disclosed F1 · derivative.exercise_price: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F1 · derivative.exercise_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F1 · derivative.expiration_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:22 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000318 · wf-form4_163598171610873.xml · derivative · entry 4 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Ordinary Shares · 1,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs convert to Ordinary Shares on a one-for-one basis. F6 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2021-2022 term. The remaining shares will vest in equal installments on each of January 31, 2022 and April 30, 2022. F6 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2021-2022 term. The remaining shares will vest in equal installments on each of January 31, 2022 and April 30, 2022. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:22 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionDividend Equivalent Units · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000318 · wf-form4_163598171610873.xml · derivative · entry 3 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16.963 Underlying: Ordinary Shares · 8 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.exercise_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.expiration_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F4 · balance_after: Upon the vesting of the RSUs, a fractional share of .4854 of related DEUs was paid in cash to the Reporting Person. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:22 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000318 · wf-form4_163598171610873.xml · nonDerivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents settlement of Dividend Equivalent Unites ("DEUs") associated with the RSUs vested. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:22 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000318 · wf-form4_163598171610873.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the second installment vesting of Restricted Stock Units ("RSUs") for board service for the 2021-2022 term. The remaining shares will vest in equal installments on each of January 31, 2022 and April 30, 2022. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 21:54 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 16.1204 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000290 · wf-form4_163165648560757.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25.4484 Underlying: Ordinary Shares · 16.1204 shares Expires not disclosed F1 · derivative.exercise_price: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F1 · derivative.exercise_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F1 · derivative.expiration_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. Read SEC document |
| July 31, 2021 Filed Aug 4, 2021 00:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000232 · wf-form4_162803597528751.xml · derivative · entry 4 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,248 Underlying: Ordinary Shares · 1,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs convert to Ordinary Shares on a one-for-one basis. F6 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2021-2022 term. These shares will vest in four installments on each of July 31, 2021, October 31, 2021, January 31, 2022 and April 30, 2022. F6 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2021-2022 term. These shares will vest in four installments on each of July 31, 2021, October 31, 2021, January 31, 2022 and April 30, 2022. Read SEC document |
| July 31, 2021 Filed Aug 4, 2021 00:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionDividend Equivalent Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000232 · wf-form4_162803597528751.xml · derivative · entry 3 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9.328 Underlying: Ordinary Shares · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.exercise_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.expiration_date: Each DEU represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F4 · balance_after: A fractional share of DEUs on the Restricted Stock Units vesting was paid in cash. Read SEC document |
| July 31, 2021 Filed Aug 4, 2021 00:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000232 · wf-form4_162803597528751.xml · nonDerivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents settlement of Dividend Equivalent Units ("DEUs") associated with the RSUs vested. Read SEC document |
| July 31, 2021 Filed Aug 4, 2021 00:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000232 · wf-form4_162803597528751.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the first installment vesting of Restricted Stock Units ("RSUs") for board service for the 2021-2022 term. These remaining shares will vest in equal installments on each of October 31, 2021, January 31, 2022 and April 30, 2022. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 00:41 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 12.4383 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000211 · wf-form4_162380403770581.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12.4383 Underlying: Ordinary Shares · 12.4383 shares Expires not disclosed F1 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. F1 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. F1 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. Read SEC document |
| June 10, 2021 Filed Jun 18, 2022 00:36 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 18,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001666769-22-000004 · wf-form4_165551258388396.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,175 F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders. Read SEC document |
| May 04, 2021 Filed May 7, 2021 01:11 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantRestricted Stock Unit · Derivative | 4,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000151 · wf-form4_162034984408127.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,331 Underlying: Ordinary Shares · 4,331 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Ordinary Shares on a one-for-one basis. F2 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2021-2022 term. These shares will vest in four installments on each of July 30, 2021, October 31, 2021, January 31, 2022 and April 30, 2022. F2 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2021-2022 term. These shares will vest in four installments on each of July 30, 2021, October 31, 2021, January 31, 2022 and April 30, 2022. Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 2,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000128 · wf-form4_162016995573425.xml · derivative · entry 4 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs convert to Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Represents a grant of Restricted Stock Units ("RSUs") for Board service for the 2020-2021 term. The remaining unvested RSUs vested on the first anniversary of the award date. F1 · derivative.expiration_date: Represents a grant of Restricted Stock Units ("RSUs") for Board service for the 2020-2021 term. The remaining unvested RSUs vested on the first anniversary of the award date. Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionDividend Equivalent Units · Derivative | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000128 · wf-form4_162016995573425.xml · derivative · entry 3 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each DEU represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.exercise_date: Each DEU represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F3 · derivative.expiration_date: Each DEU represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F4 · balance_after: A fractional share of DEUs on the RSUs vesting was paid in cash. Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000128 · wf-form4_162016995573425.xml · nonDerivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents settlement of Dividend Equivalent Units ("DEUs") associated with the RSUs vested. Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:13 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 2,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000128 · wf-form4_162016995573425.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents a grant of Restricted Stock Units ("RSUs") for Board service for the 2020-2021 term. The remaining unvested RSUs vested on the first anniversary of the award date. Read SEC document |
| April 02, 2021 Filed Apr 6, 2021 23:43 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 7.7805 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000103 · wf-form4_161775252790067.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25.5761 Underlying: Ordinary Shares · 7.7805 shares Expires not disclosed F1 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F1 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F1 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F2 · balance_after: 1.3919 DEUs were deducted from the previously reported total due to rounding differences. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:36 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 4,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012717 · doc4.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,910 F1 · price: The grant consists of RSUs that fully vest on December 29, 2021. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:01 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000015 · wf-form4_161240048266853.xml · derivative · entry 3 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Ordinary Shares · 445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The RSUs convert to Ordinary Shares on a one-for-one basis. F4 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, January 31, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. F4 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, January 31, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:01 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionDividend Equivalent Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000015 · wf-form4_161240048266853.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19.1875 Underlying: Ordinary Shares · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F2 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F2 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 01:01 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 448 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-21-000015 · wf-form4_161240048266853.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of third traunch of Restricted Stock Units ("RSUs") awarded 4/28/2020. Read SEC document |
| December 04, 2020 Filed Dec 9, 2020 00:39 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 10.3875 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000379 · wf-form4_160747438451636.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22.1875 Underlying: Ordinary Shares · 10.3875 shares Expires not disclosed F1 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F1 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. F1 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Unit ("RSUs") to which they relate. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:48 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionDividend Equivalent Units · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000341 · wf-form4_160453010310090.xml · derivative · entry 3 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11.8 Underlying: Ordinary Shares · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F4 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. F4 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying RSUs to which they relate. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:48 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000341 · wf-form4_160453010310090.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668 Underlying: Ordinary Shares · 445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Ordinary Shares on a one-for-one basis. F3 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. F3 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:48 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000341 · wf-form4_160453010310090.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of second traunch of Restricted Stock Units ("RSUs") awarded 4/28/2020. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 20:02 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | GrantStock Option (right to buy) · Derivative | 6,509 | $10.12 Strike: $10.12 | $65,871.08 |
DisclosureSEC source: 0001600132-20-000100 · wf-form4_160011376081628.xml · derivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,472 Underlying: Common Stock · 6,509 shares Expires 2030-09-10 Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 22:35 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantDividend Equivalent Units · Derivative | 12.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000298 · wf-form4_159969093561970.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12.8 Underlying: Ordinary Shares · 12.8 shares Expires not disclosed F1 · derivative.exercise_price: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. F1 · derivative.exercise_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. F1 · derivative.expiration_date: Each Dividend Equivalent Unit ("DEUs") represent a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting criteria based on the underlying Restricted Stock Units ("RSUs") to which they relate. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:08 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionRestricted Stock Unit · Derivative | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000241 · wf-form4_159658610698332.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,113 Underlying: Ordinary Shares · 445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Ordinary Shares on a one-for-one basis. F3 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. F3 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 31, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:08 UTC | DEL MONTE CORP FDP · Entity 4683 | Exercise / conversionOrdinary Shares | 445 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000241 · wf-form4_159658610698332.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of first tranche of RSUs awarded 4/28/2020. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 23:25 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantRestricted Stock Unit · Derivative | 3,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000171 · wf-form4_158828913619928.xml · derivative · entry 2 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,558 Underlying: Ordinary Shares · 3,558 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Ordinary Shares on a one-for-one basis. F2 · derivative.exercise_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 30, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. F2 · derivative.expiration_date: Represents a grant of RSUs for board service for the 2020-2021 term. 12.5% of these shares vest on each of July 30, 2020, October 31, 2020, February 28, 2021 and April 30, 2021, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 23:25 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantOrdinary Shares | 1,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001047340-20-000011 · wf-form4_157835309055887.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: Represents a grant of restricted shares under the Fresh Del Monte Produce Inc. 2014 Omnibus Share Incentive Plan reflecting board service from December 28, 2019 through April 29, 2020. 615 of these shares vest on the grant date, and the remaining 614 will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 20:51 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | GrantStock Option (right to buy) · Derivative | 46,266 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001600132-19-000129 · wf-form4_156987668534471.xml · derivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,482 Underlying: Common Stock · 46,266 shares Expires 2029-09-26 Read SEC document |
| May 01, 2019 Filed May 3, 2019 21:24 UTC | DEL MONTE CORP FDP · Entity 4683 | GrantOrdinary Shares | 2,830 | $29.44 | $83,315.20 |
DisclosureSEC source: 0001047340-19-000138 · wf-form4_155691864409537.xml · nonDerivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,830 F1 · kind: Ordinary Shares represent an annual grant of restricted shares under the Fresh Del Monte Produce Inc. 2014 Ominbus Share Incentive Plan. 50% of these shares vest on the grant date, and the remaining 50% will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. F2 · balance_after: 1,415 of these restricted shares fully vested on their respective grant date, and the remaining 1,415 restricted shares will vest upon the six-month anniversary of the date on which the recipient ceases to serve as a member of the Board of Directors. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 20:49 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | GrantStock Option (right to buy) · Derivative | 38,216 | $2.27 Strike: $2.27 | $86,750.32 |
DisclosureSEC source: 0001600132-18-000069 · wf-form4_152840454200943.xml · derivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,216 Underlying: Common Stock · 38,216 shares Expires 2028-06-04 Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:01 UTC | Bellerophon Therapeutics, Inc. BLPH · Entity 108982 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001600132-17-000105 · wf-form4_150645967793290.xml · derivative · entry 1 Cloyd Mary Ann · CIK 0001666769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-09-21 F1 · derivative.exercise_date: This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.